A Study to Evaluate the Acceptability and Preference for Contraceptive Options as Proxy for HIV Prevention Methods
NCT02404038
·
clinicaltrials.gov ↗
NA
Phase
UNKNOWN
Status
131
Enrollment
OTHER
Sponsor class
Conditions
HIV
Interventions
DRUG:
Nur-Isterate
DEVICE:
Nuvaring
DRUG:
Triphasil
Sponsor
Desmond Tutu HIV Centre